The Cooper Companies, Inc. (COO)

Nasdaq · Healthcare · Medical Instruments & Supplies
$58.88-2.40%As of 2026-11-22 · USD
Last session low $58.66Last session high $60.98
52-week low $51.0152-week high $89.83
Market cap
$11.20B
Sector
Healthcare
P/E (TTM)
20.2x
Next earnings
2026-12-03

Market data and research context for informational purposes. Not investment advice.

Technical indicators

Indicators from the 2026-11-20 daily bar; Bollinger %B and the average rows compare the latest price with those values. Prices in USD.

IndicatorValueReading
RSI (14)43.4In the neutral range (30 to 70)
MACD (12, 26, 9)0.32Below its signal line (0.74); histogram -0.42
Bollinger %B (20, 2)7%Inside the bands (58.47 to 64.63)
SMA 2061.55Price is 4.3% below
SMA 5058.37Price is 0.9% above
SMA 20067.47Price is 12.7% below
ATR (20)2.85% of priceAverage true range per day
52-week position20%In the lower part of the 51.01 to 89.83 range

About The Cooper Companies, Inc.

The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical, toric, and multifocal contact lenses that address vision challenges, such as astigmatism, presbyopia, and myopia.

Insider filings, 90 days4 purchases (about $1.9M) and no sales.
Latest fiscal yearEnded 2025-10-31: revenue of $4.09B and an operating margin of 16.7%.
Next earnings reportExpected on 2026-12-03.

More in Medical Instruments & Supplies